The contribution of observational studies to the knowledge of drug effectiveness in heart failure

Abstract

Aims Randomized controlled trials (RCTs) are the golden standard for the assessment of drug efficacy. Little is known about the add‐on value of observational studies in heart failure (HF). We aimed to assess the contribution of observational studies to actual knowledge regarding the effectiveness of angiotensin‐converting enzyme inhibitors (ACEI), and β‐blockers (BB) in HF. Methods Observational studies that assessed the effectiveness of ACEI and BB in HF were identified by searching Medline, Embase, Cochrane Database (1990–2005) and the bibliographies of published articles. Cohort, case–control and time‐series analysis studies were considered for inclusion. Studies with <100 patients and those who did not perform a multivariate analysis were excluded. Results A total of 23 cohort studies met the inclusion criteria. Studies of ACEI and BB showed a decrease in mortality with drug use in elderly patients with a broad range of ejection fraction (EF), and in those with depressed EF. Additionally, they showed a decrease in mortality in patients with renal insufficiency. The effect of ACEI and BB in HF with preserved EF was not clear, although last evidence suggests a potential benefit. Low‐dose ACEI and BB may have beneficial effects. Target doses of ACEI seemed superior to low doses, but there was no clear dose–response relationship. Conclusions Observational studies in HF validate the effectiveness of ACEI and BB in populations underrepresented or excluded from RCTs. Observational studies of drug effectiveness provide relevant additional information for clinical practice.

Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment

“…The potential specific role of gender was also explored, within subgroups of patients with different demographic and clinical features at treatment initiation. The observational study design, such as utilized in this paper, is currently considered a valuable research tool for assessing drug effectiveness in subgroups not well studied in RCTs [17,18].…”

“…Observational studies may be especially valuable for answering this kind of effectiveness questions in subgroups not studied in RCTs [17,18]. Moreover data derived from observational studies, in typical large patient populations, may complement information provided by RCTs.…”

Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: A systematic review

“…In this review, three RCTs had selection biases, affecting the result on the sex difference of DMTs response [10][11][12] (table 2). Due to this weak point of RCT design, more observational studies representing large diverse populations are needed 20,21 . Third, the gender difference in DMTs response may reflect sex disparity in the natural history of MS rather than in treatment effects.…”

Etoricoxib improves osteoarthritis pain relief, joint function, and quality of life in the extreme elderly

“…However, most of those results were based on clinical trials, which may not accurately represent daily clinical practice characterized by heterogeneous patient populations, in which patients are switched from one therapy to another without washout of drugs or flare of disease. Compared to the randomized controlled trials, observational studies carried out in "reallife" clinical settings provide a more general insight [25,35,36].…”